Qhubeka Ngokulumkela Ngokukodwa Ukuba Unayo I-Bipolar Disorder
NgoJuni noJulayi ka-2012, iDiary Food and Drug Administration (i-FDA) yavuma izidakamizwa ezimbini zokulahlekelwa kwezilwanyana, uBelviq (lorcaserin) kunye ne-Qsymia (i-phentermine / topiramate). Kubantu abaye bafumana ubunzima kwiziyobisi zengqondo, ezi ziyobisi zingabonakala zikhangayo, kodwa ngokwenene, kukho izilumkiso ezibalulekileyo.
Izilumkiso kunye neBelviq neKyysmia
Ngalunye kwezi zimbini ezinxamnye nokugqithisela kunokuba nemiphumo emibi kubantu abaneemvakalelo kunye nokuphazamiseka kokulala, kwaye kukho ukubandakanyeka okunokuba yingxaki kunye neziyobisi zengqondo.
Ukuba uthabatha unyango lweengqondo ezifana ne-serotonin reuptake inhibitors (SSRIs), i-serotonin-norepinephrine reuptake inhibitors (i-SNRIs), i-tricyclic antidepressants (TCAs), i-Wellbutrin (bupropion), i-monoamine oxidase inhibitors (i-MAOIs), i-lithium okanye i-antipsychotics, kubaluleke kakhulu ukuba Usebenza ngokusondeleyo kwaye usebenzisana kunye noogqirha abayalela ukuba babone izifo zonyango kunye nokunciphisa umzimba.
Indlela iBelviq isebenza ngayo
La mayeza asebenza kwi- serotonin , i-neurotransmitter eye yaxutyushwa kwixinzelelo. Ekubeni iingxaki ezininzi zeengqondo zisebenza kwi-serotonin system, akumangalisi ukuba kukho iziphumo ezibi kakhulu xa ezi mayeza zidibene.
Izilumkiso Xa uthatha iBelviq
I-Serotonin syndrome kunye ne-neuroleptic syndrome echaphazelekayo, kunye nezimo ezinobungozi bokuphila, zinokwenzeka ngezidakamizwa ezichaphazela i-serotonin, ngoko kwandisa i-Belviq kwimishanguzo ekhoyo ikwazi ukuphuhlisa nokuba zezi zimo zinokwenzeka.
Umngcipheko kunye nokukhuseleko kweBelviq xa kusetyenziswe nezinye iziyobisi ezichaphazela i-serotonin ayizange ihlolwe, kodwa iilebula iqulethe isilumkiso ukuba "usebenzise ulumkiso omkhulu" xa ulawula iBelviq nge-SSRIs, i-SNRIs, i-TCAs, i-Wellbutrin, i-MAOI, i-antipsychotics, i-lithium kunye ne-St. John's wort.
Iimpawu eziPhezulu zeBelviq
Imiphumo emibi yeBelviq iquka:
- Utywala
- Ukukhathala
- Intloko
- Umlomo omile
- Ukutyunjwa
- I sizathu
Indlela i-Qsymia isebenza ngayo
I-Qsymia idibaniselwano lamachiza amabini, i-phentermine, ne- Topamax (topiramate). I-Topamax yipilisi ye-anti-stroke ephindwe isetyenziswa njenge- stabilizer e-bipolar disorder. I-Phentermine isetyenziswe ukususela ngo-1959 e-US ukwenzela unyango lwexesha elifutshane kunye ne-Topamax yenziwe yi-FDA evunyelwe ukuphazamiseka kokuthintela kunye nokukhusela i-migraine.
Ngenxa yokuba izigulana ezithatha i-Topamax kulezo zimo zaye zinciphisa ubunzima, uphando lwaluqhutyelwe ngendlela ephumelelayo ngayo ekuphatheni ukukhuluphala. Ukuhlanganiswa kwezi mbini kubonakala ukuba kusebenza kakuhle ngakumbi kunokuba yedwa, kwaye yile ndlela u-Qsymia azalwa ngayo.
Izilumkiso Xa uthatha iKyysmia
Kwiminyaka embalwa edlulileyo, i-FDA ifune yonke imithi ye-anticonvulsant ukuba ithwale isilumkiso malunga nokwanda kwenyathelo lokuzibulala . Ekubeni i-Qsymia iqulethe i-topiramate, e-anticonvulsant, i-official prescription information for the drug isilumkiso sokuba i-Qsymia ingabangela izifo zengqondo. Kwakhona kuyingozi kakhulu kubantu abanembali yokudakumba ngenxa yokuba kunokubangela ukuba uxinzelelo lubuye okanye ezinye izifo zengqondo zokuphuhlisa.
Kwakhona kuthi xa iimpawu zingasuki okanye zinkathazo, i-Qysmia kufuneka iyancipha okanye ishiyiwe.
Ukuba unesigqibo sokuzibulala okanye ukuziphatha, i-Qysmia kufuneka imiswe ngokukhawuleza. Kwakungafanele kuthathwe ukuba unembali yokuzibulala okanye ukuzama.
Ezinye izixwayiso malunga neQysmia
Eminye imiba eyongezelelweyo ingaquka:
- Iingxaki xa i-Qsymia ithathwa kunye ne- benzodiazepines , uhlobo lokuxhalabisa nokuxhatshazwa ngamachiza, okanye amanye amayeza okulala.
- I-Qsymia ayifanele ithathwe ngexesha okanye kwiintsuku ezi-14 zokumisa nayiphi na i- MAOI engathandabuzekiyo .
- Inkathalo iyadingeka xa uthabatha eli liyeza kunye ne-anticonvulsant mood stabilizer, ngakumbi i-carbamazepine kunye ne-valproate.
Imiphumo emibi yeQysmia
Iziphumo ezinobungozi beCyysmia ziquka:
- Utywala
- Umlomo omile
- Ingxaki yokulala
- Ukutya kunye nokuphosa utshintsho
- Ukulinganisa
Inqaku eliphantsi kwiBelviq, i-Qsymia, kunye neengxaki zoMoya
Akunakwenzeka kubantu abaneentsholongwane ze-bipolar okanye ukuxinezeleka okukhulu ukuphathwa ngenye yeziyobisi, kodwa kuyadingeka ukuba kuqaphelwe ingqalelo. Iziphumo ezinobungozi zobomi zinokwenzeka. Kwezinye iimeko, ukuhlolwa kwegazi rhoqo kunconywa.
Sebenza kunye noogqirha bakho ngokufutshane ukuba ngaba iBelviq okanye i-Qsymia imiselwe wena, kwaye qinisekisa ukuba ubaxelele malunga naluphi na utshintsho kwimvakalelo, ukulala, uxhalabe, uxinzelelo okanye impilo yempilo. Ukulahlekelwa isisindo akufanelekanga iingxaki zempilo ezinokuthi zenzeke xa uthatha la mayeza.
Imithombo:
Ulawulo lwe-US lokuLawula kunye neziyobisi: I-Label evunyelweyo yeBelviq. 27 uJuni 2012.
I-US yokuLawula kunye nokuLawula iDrug: I-Label evunyelweyo ye-Qsymia. 17 Julayi 2012.
"Ukulahlekelwa kwesisindo: Izidakamizwa eziLawulayo ngokuPhepha." IMayo Clinic (2015).
I-Shin, JH, ne-Gadde, iKM (2013). Ubuncedo lwezonyango lwe-phentermine / topiramate (QsymiaTM) ukudibanisa kunyango lokunyanya. Isifo sikashukela, iMetabolic Syndrome kunye nokunyaniseka: Iithagethi kunye neNyango , 6 , 131-139.